225 related articles for article (PubMed ID: 11769675)
41. Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q- syndrome.
Lopez-Villar O; Garcia JL; Sanchez-Guijo FM; Robledo C; Villaron EM; Hernández-Campo P; Lopez-Holgado N; Diez-Campelo M; Barbado MV; Perez-Simon JA; Hernández-Rivas JM; San-Miguel JF; del Cañizo MC
Leukemia; 2009 Apr; 23(4):664-72. PubMed ID: 19151777
[TBL] [Abstract][Full Text] [Related]
42. Changes in RPS14 expression levels during lenalidomide treatment in Low- and Intermediate-1-risk myelodysplastic syndromes with chromosome 5q deletion.
Oliva EN; Cuzzola M; Nobile F; Ronco F; D'Errigo MG; Laganà C; Morabito F; Galimberti S; Cortelezzi A; Aloe Spiriti MA; Specchia G; Poloni A; Breccia M; Ghio R; Finelli C; Iacopino P; Alimena G; Latagliata R
Eur J Haematol; 2010 Sep; 85(3):231-5. PubMed ID: 20491881
[TBL] [Abstract][Full Text] [Related]
43. Mosaicism of the 5q deletion as assessed by interphase FISH is a common phenomenon in MDS and restricted to myeloid cells.
Kroef MJ; Bolk MJ; Muus P; Wessels JW; Beverstock GC; Willemze R; Landegent JE
Leukemia; 1997 Apr; 11(4):519-23. PubMed ID: 9096692
[TBL] [Abstract][Full Text] [Related]
44. Investigation of bone marrow involvement in malignant lymphoma using fluorescence in situ hybridization: possible utility in the detection of micrometastasis.
Huh HJ; Min HC; Cho HI; Chae SL; Lee DS
Cancer Genet Cytogenet; 2008 Oct; 186(1):1-5. PubMed ID: 18786435
[TBL] [Abstract][Full Text] [Related]
45. Cytogenetics and fluorescence in-situ hybridization in detection of hematological malignancies.
Frenny VJ; Antonella Z; Luisa A; Shah AD; Sheth JJ; Rocchi M
Indian J Cancer; 2003; 40(4):135-9. PubMed ID: 14716109
[TBL] [Abstract][Full Text] [Related]
46. [Chromosomal aberrations in myelodysplastic syndrome].
Ol'shanskaia IuV; Domracheva EV; Udovichenko AI; Vodinskaia LA; Zakharova AV; Parovichnikova EN; Tsvetaeva NV; Mikhaĭlova EA; Glasko EN; Kolosova LIu; Kokhno AN; Tikhonova LIu; Shitareva TV; Smirnova EA; Alimova GA; Shirin AD; Vinogradova OIu; Khoroshko ND; Savchenko VG
Ter Arkh; 2005; 77(7):27-33. PubMed ID: 16116905
[TBL] [Abstract][Full Text] [Related]
47. Detection of trisomy 8 by fluorescence in situ hybridization on bone marrow smears from patients with subtle myelodysplastic changes.
Brynes RK; Swayne D; McCourty A; Dosik GM; Traweek ST; Slovak ML
Arch Pathol Lab Med; 1994 Dec; 118(12):1196-200. PubMed ID: 7979913
[TBL] [Abstract][Full Text] [Related]
48. [Chromosome 13q deletion detected by interphase FISH in multiple myeloma: a study of 100 cases in China].
Li Q; Lu Y; Wang YF; Liu XP; Qi JY; Zou DH; Zhao YZ; Qiu LG
Zhonghua Yi Xue Za Zhi; 2009 Jul; 89(28):1979-82. PubMed ID: 19950573
[TBL] [Abstract][Full Text] [Related]
49. [Molecular cytogenetic analysis of -7/7q- abnormalities in patients with myeloid malignancies].
Xiao Y; Liu SH; Liu XP; Qin S; Bo LJ; Li CW; Dai Y; Wang JS
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Dec; 20(6):471-6. PubMed ID: 14669212
[TBL] [Abstract][Full Text] [Related]
50. Clinical management of myelodysplastic syndromes with interstitial deletion of chromosome 5q.
Nimer SD
J Clin Oncol; 2006 Jun; 24(16):2576-82. PubMed ID: 16735711
[TBL] [Abstract][Full Text] [Related]
51. Cytogenetic and comparative genomic hybridization study of Indian myelodysplastic syndromes.
Kawankar N; Jijina F; Ghosh K; Vundinti BR
Cancer Epidemiol; 2011 Aug; 35(4):e1-5. PubMed ID: 21193364
[TBL] [Abstract][Full Text] [Related]
52. [Detection of trisomy 8 and monosomy 7 in chronic granulocytic leukemia and myelodysplastic syndrome by cytogenetic analysis and fluorescence in situ hybridization].
Szabó Gabriella P; Balogh E; Jakab Z; Germán P; Bodnár F; Kiss A; Telek B; Oláh E
Orv Hetil; 2002 Dec; 143(50):2775-9. PubMed ID: 12583317
[TBL] [Abstract][Full Text] [Related]
53. Unusual clonal evolution involving 5q in a case of myelodysplastic syndrome with deletion 5q 31 treated with lenalidomide.
Eclache V; Da Rocha A; Le Roux G; Fenaux P
Haematologica; 2008 Feb; 93(2):315-6. PubMed ID: 18245660
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of recurring cytogenetic abnormalities in the treatment of myelodysplastic syndromes.
Olney HJ; Le Beau MM
Leuk Res; 2007 Apr; 31(4):427-34. PubMed ID: 17161457
[TBL] [Abstract][Full Text] [Related]
55. Comparison of cytogenetics with FISH in 40 myelodysplastic syndrome patients.
Romeo M; Chauffaille Mde L; Silva MR; Bahia DM; Kerbauy J
Leuk Res; 2002 Nov; 26(11):993-6. PubMed ID: 12363467
[TBL] [Abstract][Full Text] [Related]
56. Unbalanced translocation der(11)t(11;12)(q23;q13): a new recurrent cytogenetic aberration in myelodysplastic syndrome with a complex karyotype.
Yamamoto K; Hato A; Minagawa K; Yakushijin K; Urahama N; Gomyo H; Sada A; Okamura A; Ito M; Matsui T
Cancer Genet Cytogenet; 2004 Nov; 155(1):67-73. PubMed ID: 15527905
[TBL] [Abstract][Full Text] [Related]
57. [Fluorescence in situ hybridization identifies complex chromosomal aberrations in multiple myeloma].
Liu SY; Huang JW; Zhang J; Du HP; Jiang H; Li JY; Xue YQ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):685-8. PubMed ID: 18067084
[TBL] [Abstract][Full Text] [Related]
58. NRAS, FLT3 and TP53 mutations in patients with myelodysplastic syndrome and a del(5q).
Fidler C; Watkins F; Bowen DT; Littlewood TJ; Wainscoat JS; Boultwood J
Haematologica; 2004 Jul; 89(7):865-6. PubMed ID: 15257941
[TBL] [Abstract][Full Text] [Related]
59. Comparison of I-FISH and G-banding for the detection of chromosomal abnormalities during the evolution of myelodysplastic syndrome.
Pinheiro RF; Chauffaille ML
Braz J Med Biol Res; 2009 Nov; 42(11):1110-2. PubMed ID: 19855907
[TBL] [Abstract][Full Text] [Related]
60. [Molecular genetics in chronic myeloid leukemia with variant Ph translocation].
Wu W; Li JY; Zhu Y; Qiu HR; Pan JL; Xu W; Chen LJ; Shen YF; Xue YQ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Aug; 24(4):470-3. PubMed ID: 17680547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
